SlideShare a Scribd company logo
1 of 37
10 STEP  Marketing Plan for  Lasik Surgery Clinic: VISX Star S4 with IR Jeffray Marc D. Ang January 19, 2011
 
5 Steps for Part 1 (PTM and positioning) ,[object Object],[object Object],[object Object],[object Object],[object Object]
5 Steps for Part 2 (Marketing Mix & Strategy) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Positioning to the  Primary Target Market Part 1: Steps 1 to 5
1. VISX Star S4 IR Technology PTM are for patients who have blurred vision ,[object Object],[object Object],[object Object],[object Object],[object Object]
1. VISX Star 4 IR Technology PTM are for patients who have blurred vision ,[object Object],[object Object],[object Object],[object Object],[object Object]
1. VISX Star 4 IR Technology PTM are for patients who have blurred vision ,[object Object],[object Object],[object Object]
2. Patients with blurred vision needs to see and wants to perform well with improved vision correction. ,[object Object],[object Object],[object Object],[object Object]
I need to see clearly. I want to perform and finish tasks. I want to do best in everything using my clear sight. I want to do work with highest quality.
3a. VISX Star 4 IR Competitors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
3a. VISX Star 4 IR Competitors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
3b. Competitive Position Map Positioning VS. Quality Matrix VISX Star 4 IR Other LASIK Procedure Other Refractive Surgeries Contact Lenses Eye Glasses Quality of Sight Permanent improvement Sharpness of sight Personalized care
4. VISX Star S4 with IR positions strongly in a niche market opportunity ,[object Object],[object Object],[object Object],[object Object],[object Object]
5a. Based on competitor data, estimated market is P880 billion ,[object Object],[object Object],[object Object]
5b. Based on AMO study, where VISX technology is 72%, total market size is P640 billion ,[object Object],[object Object],[object Object]
5c. Based on customer data, estimated market size is P720 billion ,[object Object],[object Object],[object Object],*Estimate based on demographics (Class ABC is about 15% of the population) considering that all of them will have refractive errors or blurred vision some time in their life and seek consult for laser vision correction.
5. Concluded that VISX Technology market is 500 billion ,[object Object],[object Object],[object Object]
The Marketing Mix Strategy Part 2: Steps 6 to 10
6a. VISX Star S4 with Iris Registration VISX Star S4 Machine
6a. VISX Star S4 against competitors VS VISX Star S4 Technology Monovision Laser Eye glasses Contact lenses
6b. VISX Technology is the No.1 platform used worldwide. ,[object Object],[object Object]
7. Price estimate is P80,000. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],NOTE: No data is available from the print ad regarding price.  These are cost estimates based from actual rates.
8a. Promotions aim to provide new perspective in personalized health care. ,[object Object],[object Object]
8a. Promotion through personlized media. Referrals from Doctors Word of Mouth
8a. Promotion through print and still media. Print Ads Magazines Newspaper Billboards
8a. Promotion through live or broadcasting media. Radio Jingles Television Commercials
8a. Promotion through internet and social marketing. Twitter You Tube Facebook Blog
8b. Competitor promotions through bandwagon appeal. Television Ads Billboards Print Ads
9. VISX Technology is exclusive for LSC. Data not available from print ad.  This was based from research. ,[object Object],[object Object],[object Object],[object Object]
9. VISX Technology is exclusive for LSC. Data not available from print ad.  This was based from research.
10. VISX Star S4 Technology is a niche leader. ,[object Object]
10. VISX Star S4 Technology is a niche leader. ,[object Object]
SUMMARY
5 Steps for Part 1 (PTM and positioning) ,[object Object],[object Object],[object Object],[object Object],[object Object]
5 Steps for Part 2 (Marketing Mix & Strategy) ,[object Object],[object Object],[object Object],[object Object],[object Object]
10 STEP  Marketing Plan for  Lasik Surgery Clinic: VISX Star S4 with IR Jeffray Marc D. Ang January 19, 2011

More Related Content

What's hot

OPHTHALMOLOGY INNOVATION SHOWCASE - Aerie Pharmaceuticals
OPHTHALMOLOGY INNOVATION SHOWCASE - Aerie PharmaceuticalsOPHTHALMOLOGY INNOVATION SHOWCASE - Aerie Pharmaceuticals
OPHTHALMOLOGY INNOVATION SHOWCASE - Aerie PharmaceuticalsHealthegy
 
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaOphthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaHealthegy
 
Reaching out to patients and ophthalmologists
Reaching  out to patients and ophthalmologists Reaching  out to patients and ophthalmologists
Reaching out to patients and ophthalmologists pecrcsite
 
Anterior Segment Company Showcase - AcuFocus
Anterior Segment Company Showcase - AcuFocusAnterior Segment Company Showcase - AcuFocus
Anterior Segment Company Showcase - AcuFocusHealthegy
 
An Assessment Of The Advantages and disadvantages Of LASIK Surgery
An Assessment Of The Advantages and disadvantages Of LASIK SurgeryAn Assessment Of The Advantages and disadvantages Of LASIK Surgery
An Assessment Of The Advantages and disadvantages Of LASIK Surgeryendurablealloy685
 
Jade Therapeutics
Jade TherapeuticsJade Therapeutics
Jade TherapeuticsHealthegy
 
Valeant Pharmaceuticals
Valeant Pharmaceuticals Valeant Pharmaceuticals
Valeant Pharmaceuticals Healthegy
 
Ophthalmology Innovation Showcase 2 - SightGlass Vision
Ophthalmology Innovation Showcase 2 - SightGlass VisionOphthalmology Innovation Showcase 2 - SightGlass Vision
Ophthalmology Innovation Showcase 2 - SightGlass VisionHealthegy
 
Anterior Segment Company Showcase - Z lens
Anterior Segment Company Showcase - Z lensAnterior Segment Company Showcase - Z lens
Anterior Segment Company Showcase - Z lensHealthegy
 
OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5
OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5
OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5Healthegy
 
Emmetrope, Inc
Emmetrope, IncEmmetrope, Inc
Emmetrope, IncHealthegy
 
Anterior Segment Company Showcase - PowerVision
Anterior Segment Company Showcase - PowerVisionAnterior Segment Company Showcase - PowerVision
Anterior Segment Company Showcase - PowerVisionHealthegy
 

What's hot (20)

Clearsight
ClearsightClearsight
Clearsight
 
OPHTHALMOLOGY INNOVATION SHOWCASE - Aerie Pharmaceuticals
OPHTHALMOLOGY INNOVATION SHOWCASE - Aerie PharmaceuticalsOPHTHALMOLOGY INNOVATION SHOWCASE - Aerie Pharmaceuticals
OPHTHALMOLOGY INNOVATION SHOWCASE - Aerie Pharmaceuticals
 
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaOphthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
 
Reaching out to patients and ophthalmologists
Reaching  out to patients and ophthalmologists Reaching  out to patients and ophthalmologists
Reaching out to patients and ophthalmologists
 
Anterior Segment Company Showcase - AcuFocus
Anterior Segment Company Showcase - AcuFocusAnterior Segment Company Showcase - AcuFocus
Anterior Segment Company Showcase - AcuFocus
 
New Versus Former-Generation Diffractive Trifocal Intraocular Lens
New Versus Former-Generation Diffractive Trifocal Intraocular Lens New Versus Former-Generation Diffractive Trifocal Intraocular Lens
New Versus Former-Generation Diffractive Trifocal Intraocular Lens
 
Acufocus
AcufocusAcufocus
Acufocus
 
EPCV
EPCVEPCV
EPCV
 
Avedro
AvedroAvedro
Avedro
 
An Assessment Of The Advantages and disadvantages Of LASIK Surgery
An Assessment Of The Advantages and disadvantages Of LASIK SurgeryAn Assessment Of The Advantages and disadvantages Of LASIK Surgery
An Assessment Of The Advantages and disadvantages Of LASIK Surgery
 
Jade Therapeutics
Jade TherapeuticsJade Therapeutics
Jade Therapeutics
 
Valeant Pharmaceuticals
Valeant Pharmaceuticals Valeant Pharmaceuticals
Valeant Pharmaceuticals
 
Ophthalmology Innovation Showcase 2 - SightGlass Vision
Ophthalmology Innovation Showcase 2 - SightGlass VisionOphthalmology Innovation Showcase 2 - SightGlass Vision
Ophthalmology Innovation Showcase 2 - SightGlass Vision
 
Avedro
AvedroAvedro
Avedro
 
Anterior Segment Company Showcase - Z lens
Anterior Segment Company Showcase - Z lensAnterior Segment Company Showcase - Z lens
Anterior Segment Company Showcase - Z lens
 
OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5
OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5
OPHTHALMOLOGY INNOVATION SHOWCASE - ForSight VISION5
 
Emmetrope, Inc
Emmetrope, IncEmmetrope, Inc
Emmetrope, Inc
 
Apx investor sept 2014
Apx investor   sept 2014Apx investor   sept 2014
Apx investor sept 2014
 
Avedro
AvedroAvedro
Avedro
 
Anterior Segment Company Showcase - PowerVision
Anterior Segment Company Showcase - PowerVisionAnterior Segment Company Showcase - PowerVision
Anterior Segment Company Showcase - PowerVision
 

Similar to VISX Star S4 with Iris Registration Print Ad Marketing Plan

Caduceus Medical Corp Final 07
Caduceus Medical Corp Final 07Caduceus Medical Corp Final 07
Caduceus Medical Corp Final 07lamarl2858
 
Advanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. PresentationAdvanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. PresentationRedChip Companies, Inc.
 
Yap,ulysses joseph markman
Yap,ulysses joseph markmanYap,ulysses joseph markman
Yap,ulysses joseph markmanLolong Yap
 
Innovega e macula eyewear 2019
Innovega e macula eyewear 2019Innovega e macula eyewear 2019
Innovega e macula eyewear 2019Stephen Willey
 
Advanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor PresentationAdvanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor PresentationRedChip Companies, Inc.
 
Advanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. PresentationAdvanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. PresentationRedChip Companies, Inc.
 
Snwv corporate investor presentation - june 2014 - final
Snwv   corporate investor presentation - june 2014 - finalSnwv   corporate investor presentation - june 2014 - final
Snwv corporate investor presentation - june 2014 - finalRedChip Companies, Inc.
 
Thrive In The New Norm
Thrive In The New NormThrive In The New Norm
Thrive In The New NormSeigen Media
 
OIS@AAO 2015 Year In Review
OIS@AAO 2015 Year In ReviewOIS@AAO 2015 Year In Review
OIS@AAO 2015 Year In ReviewHealthegy
 
Advanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor PresentationAdvanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor PresentationRedChip Companies, Inc.
 
Advanced Medical Isotope Corp.- Investor Presentation
Advanced Medical Isotope Corp.- Investor Presentation Advanced Medical Isotope Corp.- Investor Presentation
Advanced Medical Isotope Corp.- Investor Presentation RedChip Companies, Inc.
 
Medvantage Tech Overview
Medvantage Tech OverviewMedvantage Tech Overview
Medvantage Tech Overviewezitizer
 
Second Sight
Second SightSecond Sight
Second SightHealthegy
 

Similar to VISX Star S4 with Iris Registration Print Ad Marketing Plan (20)

Caduceus Medical Corp Final 07
Caduceus Medical Corp Final 07Caduceus Medical Corp Final 07
Caduceus Medical Corp Final 07
 
Advanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. PresentationAdvanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. Presentation
 
Yap,ulysses joseph markman
Yap,ulysses joseph markmanYap,ulysses joseph markman
Yap,ulysses joseph markman
 
Innovega e macula eyewear 2019
Innovega e macula eyewear 2019Innovega e macula eyewear 2019
Innovega e macula eyewear 2019
 
Advanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor PresentationAdvanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor Presentation
 
AMI Investor Presentation
AMI Investor PresentationAMI Investor Presentation
AMI Investor Presentation
 
Advanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. PresentationAdvanced Medical Isotope Corp. Presentation
Advanced Medical Isotope Corp. Presentation
 
Farlah 10step plan
Farlah 10step planFarlah 10step plan
Farlah 10step plan
 
Farlah 10step plan
Farlah 10step planFarlah 10step plan
Farlah 10step plan
 
Farlah 10step plan
Farlah 10step planFarlah 10step plan
Farlah 10step plan
 
Co management with o ds2
Co management with o ds2Co management with o ds2
Co management with o ds2
 
Snwv corporate investor presentation - june 2014 - final
Snwv   corporate investor presentation - june 2014 - finalSnwv   corporate investor presentation - june 2014 - final
Snwv corporate investor presentation - june 2014 - final
 
Thrive In The New Norm
Thrive In The New NormThrive In The New Norm
Thrive In The New Norm
 
OIS@AAO 2015 Year In Review
OIS@AAO 2015 Year In ReviewOIS@AAO 2015 Year In Review
OIS@AAO 2015 Year In Review
 
AMI August Investor Presentation
AMI  August Investor PresentationAMI  August Investor Presentation
AMI August Investor Presentation
 
Advanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor PresentationAdvanced Medical Isotope Corp. Investor Presentation
Advanced Medical Isotope Corp. Investor Presentation
 
Advanced Medical Isotope Corp.- Investor Presentation
Advanced Medical Isotope Corp.- Investor Presentation Advanced Medical Isotope Corp.- Investor Presentation
Advanced Medical Isotope Corp.- Investor Presentation
 
Medvantage Tech Overview
Medvantage Tech OverviewMedvantage Tech Overview
Medvantage Tech Overview
 
Second Sight
Second SightSecond Sight
Second Sight
 
07 aker
07 aker07 aker
07 aker
 

VISX Star S4 with Iris Registration Print Ad Marketing Plan

  • 1. 10 STEP Marketing Plan for Lasik Surgery Clinic: VISX Star S4 with IR Jeffray Marc D. Ang January 19, 2011
  • 2.  
  • 3.
  • 4.
  • 5. Positioning to the Primary Target Market Part 1: Steps 1 to 5
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. I need to see clearly. I want to perform and finish tasks. I want to do best in everything using my clear sight. I want to do work with highest quality.
  • 11.
  • 12.
  • 13. 3b. Competitive Position Map Positioning VS. Quality Matrix VISX Star 4 IR Other LASIK Procedure Other Refractive Surgeries Contact Lenses Eye Glasses Quality of Sight Permanent improvement Sharpness of sight Personalized care
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. The Marketing Mix Strategy Part 2: Steps 6 to 10
  • 20. 6a. VISX Star S4 with Iris Registration VISX Star S4 Machine
  • 21. 6a. VISX Star S4 against competitors VS VISX Star S4 Technology Monovision Laser Eye glasses Contact lenses
  • 22.
  • 23.
  • 24.
  • 25. 8a. Promotion through personlized media. Referrals from Doctors Word of Mouth
  • 26. 8a. Promotion through print and still media. Print Ads Magazines Newspaper Billboards
  • 27. 8a. Promotion through live or broadcasting media. Radio Jingles Television Commercials
  • 28. 8a. Promotion through internet and social marketing. Twitter You Tube Facebook Blog
  • 29. 8b. Competitor promotions through bandwagon appeal. Television Ads Billboards Print Ads
  • 30.
  • 31. 9. VISX Technology is exclusive for LSC. Data not available from print ad. This was based from research.
  • 32.
  • 33.
  • 35.
  • 36.
  • 37. 10 STEP Marketing Plan for Lasik Surgery Clinic: VISX Star S4 with IR Jeffray Marc D. Ang January 19, 2011